Bourgeon Capital Loves These Five Stocks. Should You?
John A. Zaro, a Stanford graduate and a member of the New York Society of Security Analysts, founded Bourgeon Capital in 1999.
Posts Tagged ‘Merck & Co. Inc. (MRK)’
Why Are These Five Stocks in Focus on Tuesday?
With the earnings season in progress, investors can take a step back from following macroeconomic news and focus on the financial results reported by individual companies.
Merck & Co., Inc. (MRK), Monster Beverage Corp (MNST) Jump On Analyst Upgrades
Shares of Merck & Co., Inc. (NYSE:MRK) and Monster Beverage Corp (NASDAQ:MNST) have both moved upward today thanks to bullish ratings updates by major analysts.
Madison Street Partners Reshuffles Its Portfolio and Bets on ETFs; See Its Top Stock Picks
Steven Owsley's Madison Street Partners recently filed its 13F form for the second quarter with the SEC.
Pfizer And Merck Earnings Previews: Mega-Cap Pharmas Try To Stem Revenue Erosion
This article is temporarily removed from Insider Monkey.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Citigroup Inc (C) Top Kahn Brothers’ Portfolio
Kahn Brothers Advisors LLC is an Investment Advisor company providing brokerage and money management services to clients.
Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr.
Pfizer Inc. (PFE) Helped Kahn Brothers Beat the Market Despite BlackBerry Ltd (BBRY) Losses
Kahn Brothers, managed by Alan Kahn and Thomas Kahn managed to beat the market in the first quarter of 2015, a period during which the fund’s co-founder and longtime manager...
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
Hedge Funds Are Crazy About These Five Dow Jones Dividend Leaders
Tracking the activity of hedge funds is a great way to identify profitable investments that will help you beat the market.
Kahn Brothers’ Top Picks to Close 2014, as Founder Irving Kahn Passes at 109
Irving Kahn, the oldest active investor on Wall Street, died this week at age 109.
10 Most Popular Healthcare Stocks Among Hedge Funds
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
General Motors Company (GM), MGM Resorts International (MGM), Citigroup Inc (C): Covalent Capital Partners’ Top Picks Heading Into 2015
Robert Hockett’s Covalent Capital Partners has filed a 13F with the SEC, declaring its long equity positions at the end of 2014.
Funds Reveal New Positions in Peabody Energy Corporation (BTU), BIND Therapeutics Inc (BIND)
Two of our tracked funds have recently revealed in filings with the SEC that they’ve taken large new passive positions in a couple of stocks.
Steven Wishnia’s Highland Capital Management Discloses Top 3 Picks For Q4
In its latest 13F form filed with the U.S.
Cramer’s Top Picks:Visa Inc. (V), MasterCard Inc. (MA) and Merck & Co.Inc. (MRK)
Heading into the close of the year, Visa Inc. (NYSE:V) and MasterCard Inc.
Bristol-Myers Squibb Co (BMY) Sues Merck & Co., Inc. (MRK) Over Cancer Drug, Position Strong
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc.
Hedge Fund News: Warren Buffett, Phil Falcone & Baupost Group
It must have been a bitter moment for President Barack Obama when he got the news that his favorite economic guru not only doesn’t like paying taxes but hates America.
Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And Merck & Co. Inc. (MRK) Are Responding To Alzheimer?
CNBC's Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions...
Beech Hill Partners Top Five Holdings at the End of March
Beech Hill Partners, led by Paul Cantor, Joseph Weiss, and Will Wurm, is a traditional boutique fund that was established as a privately owned investment advisory arm of Beech...
Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Activist Alex Denner’s Sarissa Capital Bets on Ariad Pharmaceuticals Inc (ARIA), Quest Diagnostics Inc (DGX) & Others
Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings.
Merck Restructuring Takes Hold
Merck restructuring: On Tuesday, Merck & Co., Inc. (NYSE:MRK) announced that it will fire 8,500 workers.
The Pharmaceutical Industry’s 10 Biggest R&D Budgets
Innovation is everything when it comes to the pharmaceutical sector.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal
Through the years, London-based drugmaker AstraZeneca plc (ADR) (NYSE:AZN) and U.S. pharmaceutical firm Merck & Co., Inc.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ): Top Risk Factors for Heart Disease
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger on a $500 million deal...
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK), Rockwell Medical Inc (RMTI): Three Drug Classes That May Become Obsolete Within Three Years
There are few, if any, businesses in the world where innovation isn't the top priority.
Merck & Co., Inc. (MRK), Akamai Technologies, Inc. (AKAM), Cyberonics, Inc. (CYBX): Next Leaders in Technology and Health Care
In an unusual divergence, stocks belonging to the defensive health care and cyclical technology spaces delivered some of the best responses to earnings last quarter .
Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK): Everyone Wants a Piece of This Mega-Blockbuster
According to a recent Bloomberg report, Gilead Sciences, Inc.
AT&T Inc. (T), Verizon Communications Inc. (VZ): Are the Dogs of the Dow (.DJI) Still in the Race?
The Dogs of the Dow strategy involve investing equal amounts into the 10 highest-yielding dividend stocks on the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI).
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Two Reasons This Biotech Hardly Moved After a Successful Trial
Adding Esperion Therapeutics' ECT-1002 to Pfizer Inc. (NYSE:PFE)'s Lipitor lowered bad LDL cholesterol levels by 22%.
Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We’re Headed
Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer...
GlaxoSmithKline plc (GSK), Merck & Co. Inc. (MRK): HPV Vaccine for Boys Has “Good Start” in 1st Year
ATLANTA (AP) -- When the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Tyson Foods, Inc. (TSN), Merck & Co., Inc. (MRK): Food Companies Suspend Growth Meds for Animals
Top beef producer Tyson Foods, Inc. (NYSE:TSN) has decided to stop buying cattle that are fed the growth additive Zilmax, produced by Merck & Co., Inc. (NYSE:MRK).
Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health
In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Tyson Foods, Inc. (TSN), Smithfield Foods, Inc. (SFD): Merck & Co., Inc. (MRK) Buried by Industry Beef
Like a pebble rolling downhill and starting an avalanche, the decision by Tyson Foods, Inc.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?
At the same time, the pharmaceutical industry isn't without its share of risks.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player
Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab.
Merck & Co., Inc. (MRK), Sony Corporation (ADR) (SNE): How the Dow Jones Industrial Average (.DJI)’s Oldest Company Got Started
The Dow Jones Industrial Average (INDEXDJX:.DJI) has 30 components, and all but one can trace their origins to a company founded in the United States after the American Revolution...
